Glaxosmithkline | GSK - Заемный капитал

Биржевая цена
52.41
Изменение за день
-6.71 -11.35%
Ежемесячно
-11.56%
Ежегодный
35.25%
Q2 прогноз
53.52




Заемный капитал Изменить Дата
AbbVie USD 58.94B 4.03B 2025-12
Amgen USD 51.89B 1.88B 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 19.9B 720M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 37.53B 1.91B 2026-03
Merck USD 46.75B 6.78B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Zoetis USD 9.04B 1.97B 2025-12